Evidence map›Paper›PMID 41466770›Full record

ArticleFrontiers in surgery2025

Novel anatomical landmark guided puncture method in L4/L5 spine posterior interlaminar endoscopic surgery: a technical note and case series.

Bin Zheng, Tiepeng Han, Yan Liang, Haiying Liu, Panfeng Yu

Abstract read
In one paragraph

Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bin Zheng *Spine Surgery, Peking University People's Hospital, Beijing, China.
Tiepeng Han *Spine Surgery, Peking University People's Hospital, Beijing, China.
Yan LiangSpine Surgery, Peking University People's Hospital, Beijing, China.
Haiying LiuSpine Surgery, Peking University People's Hospital, Beijing, China.
Panfeng YuSpine Surgery, Peking University People's Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: L4/L5 segment lumbar disc herniation and canal stenosis commonly cause low back and leg pain. Posterior interlaminar spine endoscopy has proven efficacy, but puncture positioning relies on experience and requires multiple fluoroscopic exposures, increasing operative difficulty and radiation exposure. This study proposes a vertebral anatomy-based puncture point(Yu Landmark) to assist puncture operations. Methods: A retrospective analysis of 426 L4/L5 posterior interlaminar spine endoscopy patients is conducted, divided into Yu landmark group (205 cases) and conventional group (221 cases). The Yu landmark determines the puncture entry point through the intersection of two lines under anteroposterior fluoroscopy: a vertical line from the midpoint of the L4 inferior articular process and a tangent line from the highest point of the junction between the L4 spinous process base and L4 lamina inferior edge. Puncture efficiency, fluoroscopic usage, complications, and clinical outcomes are compared between groups. Results: The Yu landmark group shows significantly reduced fluoroscopic exposures (4.9 ± 1.4 vs. 22.7 ± 4.8), radiation dose (0.48 ± 0.23 vs. 1.34 ± 0.29 mGy), and channel establishment time (22.6 ± 4.7 vs. 29.6 ± 5.9 min) (all Conclusions: The Yu landmark is simple, objective, and reproducible, significantly reducing fluoroscopic exposure while improving puncture efficiency, providing a standardized positioning strategy for L4/L5 posterior interlaminar endoscopic surgery.

Indexed as

anatomical landmarkfluoroscopic guidanceinterlaminar approachpuncture positioningradiation dose

Identifiers

PMID41466770
PMCPMC12744902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.